Acelrx Pharmaceuticals Inc  (ACRX)
Other Ticker:  

Acelrx Pharmaceuticals Inc's



ACRX Sales vs. its Competitors Q3 2023

Comparing the current results to its competitors, Acelrx Pharmaceuticals Inc reported Revenue decrease in the 3 quarter 2023 year on year by -76.92 %, faster than the overall decrease of Acelrx Pharmaceuticals Inc's competitors by -76.92 %, recorded in the same quarter.

List of ACRX Competitors

Revenue Growth Comparisons

Net Income Comparison

Acelrx Pharmaceuticals Inc Net Income in 3 quarter 2023 declined year on year by 0 %, despite income growth by most of its competitors recorded a net loss , as well as most of its competitors.

<<  ACRX Stock Performance Comparisons

*Market share is calculated based on total revenue.

  News about Acelrx Pharmaceuticals Inc Contracts

Who are Acelrx Pharmaceuticals Inc's Competitors?


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com